Sunday, April 14, 2024 11:32:11 AM
Recent CAPR News
- Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13 • GlobeNewswire Inc. • 11/05/2024 02:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/24/2024 06:02:10 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/22/2024 09:11:23 PM
- Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 10/18/2024 08:01:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/17/2024 08:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 10:01:22 AM
- Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock • GlobeNewswire Inc. • 10/17/2024 10:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/17/2024 04:15:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/16/2024 08:35:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:25:24 PM
- Capricor Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 10/16/2024 08:17:48 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/16/2024 05:31:08 PM
- Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress • GlobeNewswire Inc. • 10/11/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 01:16:15 PM
- Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 10/09/2024 01:15:00 PM
- Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress • GlobeNewswire Inc. • 10/04/2024 01:15:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/24/2024 08:03:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:01:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 08:01:08 PM
- Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy • GlobeNewswire Inc. • 09/24/2024 12:00:00 PM
- Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024 • GlobeNewswire Inc. • 09/23/2024 01:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 01:15:10 PM
- Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 09/17/2024 01:15:00 PM
- Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences • GlobeNewswire Inc. • 09/06/2024 12:30:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM